Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1292 EUR | +1.89% | +9.86% | +21.89% |
Business Summary
All sales are abroad.
Number of employees: 3
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Medicines
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 22/12/05 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 30/06/18 |
Bruno Besse
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/17 |
Chief Tech/Sci/R&D Officer | - | - | |
General Counsel | - | 03/05/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 22/12/05 |
François Pelen
BRD | Director/Board Member | 66 | - |
Chief Executive Officer | 63 | - | |
Director/Board Member | 58 | - | |
François Durvye
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,854,981 | 30,403,091 ( 87.23 %) | 0 | 87.23 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.89% | 4.81M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALQGC Stock
- Company Quantum Genomics